Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
COX-2-IN-6 is a gut-restricted COX-2 inhibitor (IC50 = 0.84 µM).1 It is selective for COX-2 over COX-1 (IC50 = >50 µM). COX-2-IN-6 inhibits the production of PGE2 (Item No. 14010) in HEK293 cells expressing COX-2 but not those expressing COX-1 (IC50s = 0.6 and >50 µM, respectively). In vivo, COX-2-IN-6 (300 mg/kg) selectively accumulates in the colon versus the plasma at a ratio of 492:1 and reduces total ileum polyp area in an ApcMin/+ mouse model of familial adenomatous polyposis (FAP) and colorectal cancer.
WARNING This product is not for human or veterinary use.
1. Gut-